化学科研者一站式服务平台

化合物简介

Palbociclib (also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.

基本信息

CAS:571190-30-2
中文别名:6-乙酰基-8-环戊基-5-甲基-2-[[5-(1-哌嗪基)-2-吡啶基]氨基]-吡啶并[2,3-d]嘧啶-7(8H)-酮;6-乙酰基-8-环戊基-5-甲基-2-[[5-(哌嗪-1-基)吡啶-2-基]氨基]-8H-吡啶并[2,3-d]嘧啶-7-酮;
英文别名:PD332991;PD 0332991;Palbociclib;6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one;
分子式:C24H29N7O2
分子量:447.533
精确质量:447.238
Psa:105.04
Logp:3.4326

编号系统

MDL号:MFCD11840850

物化性质

密度:1.313g/cm3
沸点:711.5ºC at 760 mmHg
熔点:200ºC
闪点:384.1ºC
折射率:1.647

安全信息

生产方法及用途

合成路线

上游原料

下游产品

图谱

13C NMR : Predict


加载中...